Profiling Parkinson's Disease

Parkinson's disease is a progressive, neurodegenerative disorder that affects both motor and cognitive function. The etiology of the disease is mostly unknown, but it probably involves both environmental and genetic. This feed focuses on profiling and defining Parkinson’s disease using biological and computational methods.

January 16, 2022

Using Telemedicine to Assess and Manage Psychosis in Neurodegenerative Diseases in Long-Term Care.

Journal of the American Medical Directors Association
Lynn ShaughnessyGeorge Grossberg
January 16, 2022

The impact of motion artifacts on quantitative optical coherence tomography angiography analysis in Parkinson's disease.

Parkinsonism & Related Disorders
Mahdy RanjbarNorbert Brüggemann
January 16, 2022

Prediagnostic Progressive Supranuclear Palsy - Insights from the UK Biobank.

Parkinsonism & Related Disorders
Duncan StreetJames B Rowe
January 15, 2022
Preprint
Open Access

Drug Contraindications in Comorbid Diseases: a Protein Interactome Perspective

BioRxiv : the Preprint Server for Biology
K. B. KarunakaranN. Balakrishnan
January 16, 2022
Review

N6-methyladenosine and Neurological Diseases.

Molecular Neurobiology
Nan ZhangLielian Zuo
January 16, 2022

Clinical and imaging evidence of brain-first and body-first Parkinson's disease.

Neurobiology of Disease
Jacob HorsagerMichael Sommerauer
January 15, 2022
Open Access

Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson's disease.

Communications Biology
Gabriela NovakAlexander Skupin
January 15, 2022

The impact of probable rapid eye movement sleep behavior disorder on Parkinson's disease: A dual-tracer PET imaging study.

Parkinsonism & Related Disorders
Qian XuChuantao Zuo
January 14, 2022

Dopamine D2L receptor density influences the recruitment of β-arrestin2 and Gi1 induced by antiparkinsonian drugs.

Neuropharmacology
Mattia FerraioloEmmanuel Hermans
January 14, 2022

Effects of vitamin D (VD3) supplementation on the brain mitochondrial function of male rats, in the 6-OHDA-induced model of Parkinson's disease.

Neurochemistry International
Ludmila Araújo de LimaGlauce Socorro de Barros Viana
January 14, 2022

Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition.

Brain, Behavior, and Immunity
Sara Konstantin NissenMarina Romero-Ramos
January 13, 2022
Preprint
Open Access

Genetic overlap between Parkinson disease and inflammatory bowel disease

MedRxiv : the Preprint Server for Health Sciences
Xiaoying KangK. Wirdefeldt

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/profiling-parkinsons-disease/2811fd14-a503-4d8d-a3c8-d074ace413bd